Gwendolyn K. Binder-Scholl's most recent trade in Cabaletta Bio Inc was a trade of 11,312 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on Jan. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 21 Jan 2026 | 11,312 | 31,312 (0%) | 0% | 2.2 | 24,763 | Common Stock |
| Instil Bio Inc | Gwendolyn K. Binder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 176,000 | 176,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 176,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 160,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 130,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 66,667 | 66,667 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 66,667 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 29,908 | 29,908 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 29,908 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 145,000 | 145,000 | - | - | Stock Option (Right to Buy) |